09:54 AM EST - Bausch + Lomb Corporation : Today announced the commercial launch of the enVista Aspire monofocal and toric intraocular lenses (IOLs) in the European Union after receiving a CE Mark late last year. enVista Aspire combines novel Intermediate Optimized optics, which are designed for a broader depth of focus*, with the proven benefits of the enVista® platform to address vision needs in today’s modern, digital world. Bausch + Lomb Corporation
shares T.BLCO are trading down $0.03 at $25.70.
